Apr 20 | News
American Oriental Bioengineering, Inc., today announced that four out of its five manufacturing subsidiaries are undergoing onsite short notice inspections directed by China State Food and Drug Administration ("SFDA").
|
Apr 16 | News
BEIJING (AP) — China's State Food and Drug Administration has suspended the sale of 13 drugs that it says are believed to have been made with capsules that contain excessive chromium.
|
Jan 18 | News
Novartis said today that it received Chinese regulatory approval for its eye drug Lucentis, and it is launching the diabetes treatment Galvus in China.
|
Nov 8 2010 | News
WuXi PharmaTech, a pharmaceutical, biotechnology and medical device research and
development outsourcing company with operations in China and the United States,
today announced that it had been awarded a Certificate of Good
Laboratory Practice (GLP) compliance from the State Food and Drug
Administration (SFDA), China's
regulatory authority for pharmaceuticals, for its toxicology facility in
Suzhou.
|
Aug 12 2010 | News
Simcere Dongyuan Pharmaceutical Co., Ltd. has recently received SFDA new drug certification and registration approval to manufacture and market Palonosetron material and injections in China.
|
Jun 15 2010 | News
NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced that its Suzhou Erye pharmaceutical subsidiary ("Erye") passed the government inspection by the State Food and Drug Administration ("SFDA") in China to manufacture penicillin powder for injection and cephalosporin powder for injection at its new manufacturing facility which provides 50% greater manufacturing capacity than its existing plant.
|
Jun 14 2010 | News
BEIJING (AP) — The deputy head of China's food and drug regulator is being investigated and has been dismissed from his post, a state news agency said Sunday, citing an anti-corruption agency.
|
Jun 1 2010 | News
Sinovac Biotech Ltd., a China-based vaccine manufacturer, announced today that it has received the confirmation from the China International Tendering Company that Sinovac was selected by the Beijing Centers for Diseases Control and Prevention (Beijing CDC) to supply the Company's hepatitis A vaccine, Healive, to the Beijing Expanded Program of Immunization (EPI).
|
May 5 2010 | News
Sinovac Biotech Ltd., a China-based vaccine manufacturer, announced today that its 30%-owned joint venture, Sinovac Dalian, has submitted an application to China's State Food and Drug Administration (SFDA) to commence human clinical trials for its mumps vaccine.
|